Heart Failure

The AJMC® Heart Failure compendium is a comprehensive resource for clinical news and expert insights for the chronic condition in which the heart doesn't pump enough blood due to damaged heart muscle.

Latest News

the top 5 heart failure content of 2024
Top 5 Most-Read Heart Failure Articles of 2024

December 23rd 2024

Some of the top heart failure research looked at statins and semaglutide for heart failure with preserved ejection fraction, diabetes-related heart failure risks, and the protective cardiovascular effects of COVID-19 vaccination.

Top 5 conference coverage of 2024
Top 5 Conference Coverage of 2024

December 17th 2024

Highlights From ESC Congress 2024
ICYMI: Highlights From ESC Congress 2024

December 12th 2024

Tirzepatide box sold as Mounjaro | Image credit: Cynthia – stock.adobe.com
How Tirzepatide Benefits Patients With Obesity-Related HFpEF

December 5th 2024

Doctor writing prescription | Image credit: 18percentgrey – stock.adobe.com
SGLT2i Prescriptions for Heart Failure Are Rising, but Vary Across US

November 18th 2024

Heart Failure Clinical and Economic Burden

An in-depth discussion on the clinical and economic burden of treatment for patients with heart failure, with special consideration to progressive disease.

John McMurray screenshot
Continuing Medical Education
View All
January 29th 2025

Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment

1.5 Credits / Cardiology, Neurology, Rare Diseases
January 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
January 29th 2025

Evidence-Based Guidelines Point to Leap in Care for Hypertrophic Cardiomyopathy

1.0 Credit / Cardiology

More News

Image of ECG
November 15th 2022

Sacubitril/Valsartan Linked to Improved Cardiac Autonomic Nervous System in HFrEF

Maggie L. Shaw
This international study, from investigators in Germany and Austria, looked at the effect sacubitril/valsartan can have among patients who have heart failure with reduced ejection fraction (HFrEF) and the impact on their cardiac autonomic nervous system.
Amresh Raina, MD, Allegheny Health Network
November 12th 2022

Dr Amresh Raina Addresses Gender Differences in HF Presentation

Maggie L. Shaw
Disease symptomatology may be the same, but the presentation of heart failure (HF) and heart attacks differ between women and men, explained Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of IV line
November 10th 2022

Comorbid Septic Shock, HFrEF Linked to Lack of Guideline-Recommended Treatment

Maggie L. Shaw
Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated with fluids—more data are needed on outcomes following fluid administration.
Amresh Raina, MD, Allegheny Health Network
November 1st 2022

Dr Amresh Raina Illuminates Top Concerns in Asymptomatic Heart Failure

Maggie L. Shaw
Risk factors not properly addressed in patients with asymptomatic heart failure, such as high blood pressure and having diabetes or mild heart valve problems, can lead to structural heart problems or heart failure itself, noted Amresh Raina, MD, of the Allegheny Health Network in Pittsburgh, Pennsylvania.
Graphic of the words "heart failure"
October 26th 2022

Increasing HF-Related Mortality Concerning Among Young Adults, Experts Say

Maggie L. Shaw
The limited data on heart failure (HF)-related mortality among young adults, those aged 15 to 44 years, prompted this analysis of data from 1999 to 2019 that considered HF as a contributing or underlying cause of death.
Image of a patient standing out
October 21st 2022

Black Patients’ Uptake of Advanced HF Treatments Falls Behind That of White Patients

Maggie L. Shaw
Despite known racial disparities in access to advanced heart failure (HF) treatments, the reasons for this continue to require further exploration. In this new study, investigators searched for associations between ventricular assist device use and heart transplant and race (Black or White).
Amresh Raina, MD, Allegheny Health Network
October 19th 2022

Dr Amresh Raina Explains Radiation’s Impact on the Heart

Maggie L. Shaw
There is potential impact on the heart, coronary arteries, and heart function following radiation to the left side of the body, explained Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of a sick kid in the hospital
October 10th 2022

Heart Transplants Delayed During COVID-19 Pandemic for Pediatric Patients

Maggie L. Shaw
The impact of the COVID-19 pandemic on pediatric heart transplant waiting list times was evaluated in this new study that used data from the United Network for Organ Sharing.
Image of women vs men
October 5th 2022

Treatment Disparities Persist for Women vs Men Following MI

Maggie L. Shaw
Outcomes following a heart attack, or myocardial infarction (MI), were assessed among a large patient population in Ontario, Canada.
Amresh Raina, MD, Allegheny Health Network
October 3rd 2022

Dr Amresh Raina: Cancer Treatments Are Affecting Heart Function in Many Ways

Maggie L. Shaw
Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania, is a board-certified advanced heart failure cardiologist, who is also certified in echocardiography and general cardiology.
Image of a person gently holding a heart
September 29th 2022

Worsened HF Outcomes Linked to Circulating Endotrophin Levels

Maggie L. Shaw
This potential outcome was particularly evident among study participants who had heart failure (HF) with preserved ejection fraction, a subtype of HF with few therapeutic options.
Amresh Raina, MD, Allegheny Health Network, Pittsburgh, PA
September 25th 2022

Dr Amresh Raina on the Importance of Treating Dominant Disease Physiology in Comorbid HF

Maggie L. Shaw
When mapping out treatment strategy, it is important to first establish dominant disease physiology in patients who have heart failure (HF) and pulmonary hypertension, explained Allegheny Health Network's Amresh Raina, MD.
Identifying Unmet Needs Surrounding Patients With Heart Failure
September 23rd 2022

Identifying Unmet Needs Surrounding Patients With Heart Failure

The panel of experts provide their final insights regarding unmet needs surrounding treatment management of heart failure.
Patient and Provider Perceptions Surrounding Affordability for HF Treatments
September 23rd 2022

Patient and Provider Perceptions Surrounding Affordability for HF Treatments

Experts share their thoughts on payer and provider perceptions surrounding affordable HF care, as well as strategies to manage care-associated costs.
Navigating Multidisciplinary HF Treatment With Multiple Comorbidities
September 23rd 2022

Navigating Multidisciplinary HF Treatment With Multiple Comorbidities

Multiple comorbidities lead to an emphasis on multidisciplinary care management when determining the most effective HF treatment strategies.
Russell Rotondo, MD, FACC, Cohere Health
September 18th 2022

Contributor: Improving Utilization Management Can Better Outcomes, Cut Costs in Cardiovascular Care

Russell Rotondo, MD, FACC
Russell Rotondo, MD, FACC, medical director of clinical strategy and innovation for cardiology at Cohere Health, discusses the myriad positive ways utilization management programs can have an impact on patient outcomes in cardiovascular care.
Amresh Raina, MD, Allegheny Health Network
September 14th 2022

Dr Amresh Raina Discusses How Heart Failure and Pulmonary Hypertension Intersect

Maggie L. Shaw
Amresh Raina, MD, is director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania.
Image of cardiac care
September 7th 2022

TAVR May Induce Early LVEF Improvement in Heart Failure

Maggie L. Shaw
This study investigated long-term mortality outcomes following transcatheter aortic valve replacement (TAVR) among patients with a left ventricular ejection fraction (LVEF) below 50% and comorbid severe aortic stenosis.
Image of a broken heart
August 29th 2022

Methamphetamine Misuse Increases Risk of Adverse Heart Health Outcomes

Maggie L. Shaw
This new study investigated risk factors for cardiovascular disease, including heart failure, among hospitalized patients with a recent history of methamphetamine use and priority patient populations to target.
What We're Reading
August 24th 2022

What We’re Reading: Premature Death Risk Factors; Pfizer Vaccine Efficacy; CVD Symptom Disparities

AJMC Staff
People who experienced childhood poverty and other adversities are at greater risk of premature death in adulthood; Pfizer’s COVID-19 vaccine is 73% effective in protecting children younger than 5 years; women experience more symptoms of heart failure and other cardiovascular diseases than men.
Image of a stethoscope in the shape of a heart
August 23rd 2022

Low-Dose Edoxaban Safe, Effective in Older Patients With AFib, High Bleeding Risk

Maggie L. Shaw
This subanalysis of data from the ELDERCARE-AF trial investigated the safety and effectiveness of a 15-mg daily dose of the factor Xa inhibitor among older patients who have atrial fibrillation (AFib).
Image of stacked quarters
August 16th 2022

Sacubitril/Valsartan Adherence Drop Linked to Lower Household Income

Maggie L. Shaw
Entresto (sacubitril/valsartan) is approved for use in adult and pediatric heart failure, and previous research shows it to be cost-effective in the long term.
Doctors consulting one another
August 10th 2022

Heart Failure Prognosis Not Improved by Risk Score Prediction

Maggie L. Shaw
The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.
New HF Guidelines Put Focus on Prevention, Bozkurt Says
August 8th 2022

New HF Guidelines Put Focus on Prevention, Bozkurt Says

Mary Caffrey
New heart failure guidelines redefine stages of the disease to emphasize prevention, said Biykem Bozkurt, MD, PhD, but more must be done by payers to identify those at high risk.
Martha Gulati, MD, MS
August 1st 2022

Gulati on Unequal CV Treatment for Women: “There Is a Bias in Our Care”

Mary Caffrey
Martha Gulati, MD, MS, kicked off the symposium “Saving the Hearts of Women Through Prevention” ahead of the 2022 Congress of the American Society for Preventive Cardiology, which took place Friday through Sunday in Louisville, Kentucky.
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care
July 30th 2022

Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care

Mary Caffrey
Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
graphic of heart in human body
July 27th 2022

Disparities in Left Ventricular Assist Device Implantation Based on Race, Sex

Hayden E. Klein
Medicare beneficiaries with heart failure who are Black or female were less likely to receive a left ventricular assist device (LVAD) implantation compared with White and male beneficiaries.
Image of a stethoscope and $100 bills
July 24th 2022

Air Pollution Exposure Linked With High Health Care Costs in Older People

Lindsey Mulrooney
Long-term exposure to traffic-related air pollution was linked with higher annual emergency department and outpatient health care costs for older patients, particularly those with cardiovascular disease.
Image of a salt shaker
July 18th 2022

Too Little Salt May Have an Adverse Impact on People Living With HFpEF

Maggie L. Shaw
This new study investigated the impact of overly restrictive salt-intake guidelines on patients living with heart failure with preserved ejection fraction (HFpEF), because despite accounting for half of all HF cases, this patient population is often excluded from studies in the space.
Health System Must Do More to Understand Heart Failure in Women, Panelists Say
July 14th 2022

Health System Must Do More to Understand Heart Failure in Women, Panelists Say

Mary Caffrey
Panelists in Wednesday’s webinar, “Don’t Skip Her Beat,” addressed gender disparities in heart failure treatment and offered advice for how women can seek the best care.
<123456789
...
21>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo